Drug Watch: Agents in late-stage development for the treatment of epilepsy/seizure disorders (PDF) (May 2010)

News
Article

Agents in late-stage development for the treatment of epilepsy/seizure disorders.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations

Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations

Denise Myshko
September 12th 2025
Article

Read More

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

Denise Myshko
September 12th 2025
Article

Read More

Nomad_Soul-stock@adobe.com

Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s

Denise Myshko
September 12th 2025
Article

Read More

Peter Togel-stock@adobe.com

Teva Launches First Generic GLP-1 Drug for Obesity

Formulary Watch
September 12th 2025
Article

Read More

freebird7977-stock@adobe.com

Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care

Denise Myshko
September 12th 2025
Article

Read More

olgakris-stock@adobe.com

Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial

Denise Myshko
September 12th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.